Antidepressant fluvoxamine may reduce risk of Covid-19 hospitalisation
Researchers treated 739 randomly selected Brazilian COVID-19 patients with fluvoxamine, with another 733 receiving a placebo, between January 15 to August 6 of this year.
Researchers treated 739 randomly selected Brazilian COVID-19 patients with fluvoxamine, with another 733 receiving a placebo, between January 15 to August 6 of this year. https://ift.tt/3vTENw4 October 27, 2021 at 09:08PM
Researchers treated 739 randomly selected Brazilian COVID-19 patients with fluvoxamine, with another 733 receiving a placebo, between January 15 to August 6 of this year. https://ift.tt/3vTENw4 October 27, 2021 at 09:08PM
Comments
Post a Comment